We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Noninvasive Neurostimulator Helps Prevent Cluster Headaches

By HospiMedica International staff writers
Posted on 12 Dec 2018
A novel non-invasive vagus nerve stimulation (nVNS) device excites the nerve’s afferent fibers, leading to headache pain reduction.

The electroCore (Basking Ridge, NJ, USA) gammaCore is hand-held adjunctive therapy device indicated for the prevention of cluster headaches and for the treatment of the acute pain associated with episodic cluster headache and migraine. More...
The portable device provides a mild electrical stimulation to the vagus nerve, without the potential side effects associated with commonly prescribed drugs. The self-administered treatment consists of three consecutive two-minute stimulations twice a day, with the first treatment applied within one hour of waking up and the second seven to 10 hours later; the device does not prevent migraines.

In two clinical studies, nVNS patients had 3.9 fewer cluster attacks per week than those who received standard of care (SOC). In addition, 40% of those patients who received gammaCore in addition to SOC experienced a 50% or greater reduction in weekly cluster attacks, compared to 8.3% of patients who received SOC alone. Also, a 57% decrease in the frequency of abortive medication use among those who received gammaCore plus SOC care was demonstrated, while those patients who received SOC alone did not experience a substantial reduction.

“Clearance of gammaCore for adjunctive use for the preventive treatment of cluster headache has the potential to help the approximately 350,000 Americans impacted by this debilitating condition, often referred to as a suicide headache,” said Frank Amato, CEO of electroCore. “We are pleased that cluster headache patients now have a FDA-cleared option, and one that is both safe and effective, especially given the difficulty in treating cluster headache and the limitations of current treatments.”

Cluster headache is a rare but extremely painful disorder characterized by recurring unilateral attacks. The condition is the least common type of headache disorder, occurring in 1-2 out of 1,000 individuals, affecting predominantly males, heavy smokers and those with a family history. Symptoms typically manifest by age 30. Frequently nicknamed “suicide headache” due to the severity of pain associated with their occurrence, cluster headache bouts occur rapidly and with variable frequency, but often at the same time each year or day and are often more frequent at night.

Related Links:
electroCore


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Glucose Meter
StatStrip®
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.